Connect with us

Technology

IAS Reports Second Quarter 2024 Financial Results

Published

on

Total revenue increased 14% to $129.0 million

Net income of $7.7 million at a 6% margin; adjusted EBITDA increased to $46.2 million at a 36% margin 

Raises full year financial guidance on positive second quarter results and strong second half outlook

NEW YORK, Aug. 1, 2024 /PRNewswire/ — Integral Ad Science (Nasdaq: IAS), a leading global media measurement and optimization platform, today announced financial results for the second quarter ended June 30, 2024.

“We are excited to report double-digit revenue growth in all of our businesses in the second quarter reflecting strong customer adoption of our leading AI-backed products across formats and channels,” said Lisa Utzschneider, CEO of IAS. “Measurement revenue grew 17% with a 34% increase in social media revenue, optimization revenue increased 11%, and publisher revenue increased 12%. IAS is leading the way with trust, transparency, and innovation to provide actionable results and superior returns for global marketers. We are raising our full year outlook and remain focused on delivering sustainable, profitable growth.”

Second Quarter 2024 Financial Highlights

Total revenue was $129.0 million, a 14% increase compared to $113.7 million in the prior-year period.Optimization revenue was $58.5 million, an 11% increase compared to $52.8 million in the prior-year period.Measurement revenue was $52.7 million, a 17% increase compared to $44.9 million in the prior-year period.Publisher revenue was $17.8 million, a 12% increase compared to $15.9 million in the prior-year period.International revenue, excluding the Americas, was $40.1 million, a 16% increase compared to $34.7 million in the prior-year period, or 31% of total revenue for the second quarter of 2024.Gross profit was $101.9 million, a 13% increase compared to $89.8 million in the prior-year period. Gross profit margin was 79% for the second quarter of 2024.Net income was $7.7 million, or $0.05 per share, unchanged from the prior-year period. Net income margin was 6% for the second quarter of 2024. Net income for the second quarter of 2023 includes $23.5 million of stock-based compensation expense related to return-target options as well as an income tax benefit of $29.1 million in the period.Adjusted EBITDA* increased to $46.2 million, a 24% increase compared to $37.4 million in the prior-year period. Adjusted EBITDA* margin was 36% for the second quarter of 2024.Cash and cash equivalents were $70.6 million at June 30, 2024.

Recent Business Highlights

YouTube Brand Safety and Suitability Measurement Expansion – In June, IAS expanded its brand safety and suitability measurement product for YouTube to include reporting for Performance Max and Demand Gen campaigns on Google Ads.Reddit Partnership – In June, IAS announced a partnership with Reddit to provide advertisers with the confidence to scale their campaigns across Reddit through IAS’s AI-driven Total Media Quality (TMQ) product suite.Pinterest Partnership – In June, IAS announced a partnership with Pinterest to provide global advertisers with greater transparency into campaigns across Pinterest’s in-app feed through IAS’s AI-driven Total Media Quality (TMQ) brand safety product.Amazon Expanded Global Measurement – In May, IAS launched its expanded reporting and insights for Amazon DSP media buys. Through a server-to-server (S2S) integration on Amazon DSP, advertisers will now have access to measurement coverage for campaigns across Amazon custom audiences and Twitch inventory. IAS’s solutions available to advertisers in Amazon DSP include viewability, invalid traffic (IVT), and brand safety and suitability.Lunio Partnership – In June, IAS teamed up with Lunio in a first-to-market partnership to provide post-click measurement and protection across search, social, and display networks. The partnership builds on IAS’s existing ad fraud detection and mitigation capabilities, giving marketers the most comprehensive invalid traffic (IVT) protection in the industry.Sincera Partnership – In June, IAS and Sincera announced a multi-year, strategic partnership to enhance AI-driven measurement and optimization solutions to drive omnichannel media quality. The partnership provides IAS with unique metadata to enhance media quality and drive unique solutions across channels including the open web, CTV, in-app, and social.Deepfake Detection Availability – In June, IAS announced availability in Beta testing of the industry’s first deepfake measurement offering, enabling advertisers to avoid running adjacent to deepfake content as part of the Global Alliance for Responsible Media (GARM)-defined Brand Safety Floor and Suitability Framework misinformation category.Election Lab Launch – In May, IAS launched the IAS Election Lab which aims to provide strategic guidance and actionable insights for advertisers during the global election season.ISO 27001 Certification – In May, IAS achieved ISO 27001:2022 certification for its Information Security Management System. ISO/IEC 27001 is the global standard for information security management systems.

Financial Outlook

“Our second quarter results further validate our scalable and profitable business model. We are driving top-line growth and investing in strategic growth initiatives while maintaining a strong financial position with an adjusted EBITDA margin of 36%, healthy cash flows, and low debt,” said Tania Secor, CFO of IAS. “We are raising our 2024 outlook based on our second quarter performance and our expectations for increased revenue growth in the second half of the year.”

IAS is introducing the following financial outlook for the third quarter of 2024 and increasing its full year 2024 revenue and adjusted EBITDA outlook:

Third Quarter Ending September 30, 2024:

Total revenue of $137 million to $139 millionAdjusted EBITDA* of $48 million to $50 million

Year Ending December 31, 2024:

Total revenue of $538 million to $544 millionAdjusted EBITDA* of $180 million to $184 million

* See “Supplemental Disclosure Regarding Non-GAAP Financial Information” section herein for an explanation of these measures. IAS is unable to provide a reconciliation for forward-looking guidance of adjusted EBITDA and corresponding margin to net income (loss), the most closely comparable GAAP measures without unreasonable effort, because certain material reconciling items, such as depreciation and amortization, interest expense, income tax expense (benefit) and acquisition, restructuring and integration expenses, cannot be estimated due to factors outside of IAS’s control and could have a material impact on the reported results. However, IAS estimates stock-based compensation expense for the third quarter of 2024 in the range of $16 million to $17 million and for the full year 2024 in the range of $63 million to $65 million.

INTEGRAL AD SCIENCE HOLDING CORP.

CONDENSED CONSOLIDATED BALANCE SHEETS

(UNAUDITED)

 

(IN THOUSANDS, EXCEPT SHARE DATA)

June 30, 2024

December 31, 2023

ASSETS

Current assets:

Cash and cash equivalents

$        70,603

$      124,759

Restricted cash

275

54

Accounts receivable, net

75,233

74,609

Unbilled receivables

45,320

46,548

Prepaid expenses and other current assets

38,251

18,959

Total current assets

229,682

264,929

Property and equipment, net

4,076

3,769

Internal use software, net

47,578

40,301

Intangible assets, net

159,825

178,908

Goodwill

674,350

675,282

Operating lease right-of-use assets

21,223

21,668

Deferred tax asset, net

2,438

2,465

Other long-term assets

4,950

4,402

Total assets

$   1,144,122

$   1,191,724

LIABILITIES AND STOCKHOLDERS’ EQUITY

Current liabilities:

Accounts payable and accrued expenses

$        51,096

$        72,232

Operating lease liability

9,483

9,435

Due to related party

121

Deferred revenue

558

682

Total current liabilities

61,137

82,470

Deferred tax liability, net

16,884

20,367

Long-term debt

93,957

153,725

Operating lease liabilities, non-current

18,397

19,523

Other long-term liabilities

6,171

6,183

Total liabilities

196,546

282,268

Commitments and Contingencies (Note 13)

Stockholders’ Equity

Preferred Stock, $0.001 par value, 50,000,000 shares authorized at June 30, 2024; 0 shares
issued and outstanding at June 30, 2024 and December 31, 2023.

Common Stock, $0.001 par value, 500,000,000 shares authorized, 160,786,740 and
158,757,620 shares issued and outstanding at June 30, 2024 and December 31, 2023, respectively.

161

159

Additional paid-in-capital

934,194

901,259

Accumulated other comprehensive loss

(2,168)

(916)

Retained earnings

15,389

8,954

Total stockholders’ equity

947,576

909,456

Total liabilities and stockholders’ equity

$   1,144,122

$   1,191,724

 

INTEGRAL AD SCIENCE HOLDING CORP.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME
(UNAUDITED)

Three Months Ended June 30,

Six Months Ended June 30,

(IN THOUSANDS, EXCEPT SHARE AND PER SHARE DATA)

2024

2023

2024

2023

Revenue

$       129,005

$       113,651

$       243,535

$       219,743

Operating expenses:

Cost of revenue (excluding depreciation and amortization shown below)

27,094

23,819

53,255

45,501

Sales and marketing

29,572

31,702

61,397

57,962

Technology and development

17,487

21,110

35,465

36,639

General and administrative

24,679

42,339

46,059

63,062

Depreciation and amortization

15,709

13,521

30,789

26,346

Foreign exchange loss (gain), net

315

(631)

1,884

(1,147)

Total operating expenses

114,856

131,860

228,849

228,363

Operating income (loss)

14,149

(18,209)

14,686

(8,620)

Interest expense, net

(1,536)

(3,221)

(3,462)

(6,638)

Net income (loss) before income taxes

12,613

(21,430)

11,224

(15,258)

(Provision) benefit for income taxes

(4,923)

29,107

(4,789)

26,081

Net income

$           7,690

$           7,677

$           6,435

$         10,823

Net income per share – basic and diluted

$             0.05

$             0.05

$             0.04

$             0.07

Weighted average shares outstanding:

Basic

160,502,795

155,425,264

159,954,926

155,267,531

Diluted

163,748,596

162,634,310

164,198,233

160,850,434

Other comprehensive income:

Foreign currency translation adjustments

(193)

(221)

(1,252)

928

Total comprehensive income

$           7,497

$           7,456

$           5,183

$         11,751

 

Stock-Based Compensation 

(UNAUDITED)

Three Months Ended June 30,

Six Months Ended June 30,

(IN THOUSANDS)

2024

2023

2024

2023

Cost of revenue

$               82

$             126

$             206

$             210

Sales and marketing

3,435

8,258

9,173

12,145

Technology and development

4,799

7,362

9,198

10,532

General and administrative

6,688

24,689

12,165

28,854

Total stock-based compensation

$         15,004

$        40,4351

$         30,742

$         51,741

1

1

During the three and six months ended June 30, 2023, with the filing of a “shelf” registration statement on Form S-3, the market condition and the implied performance condition relating to the Return-Target Options were deemed to be probable and the Company recognized $23.5 million of stock-based compensation expense for such options in both the three and six months ended June 30, 2023. This is broken out as follows; $2.1 million of sales and marketing expense, $2.6 million of technology and development expense and $18.8 million of general and administrative expense.

 

INTEGRAL AD SCIENCE HOLDING CORP.

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY

(UNAUDITED)

Three Months Ended June 30, 2024

Common Stock

(IN THOUSANDS, EXCEPT SHARES)

Shares

Amount

Additional

paid-in

capital

Accumulated
other
comprehensive
loss

Retained
earnings

Total

stockholders’

equity

Balance, March 31, 2024

159,761,454

$               160

$       919,192

$          (1,975)

$            7,699

$       925,076

RSUs and MSUs vested

1,025,286

1

1

Stock-based compensation

15,002

15,002

Foreign currency translation adjustment

(193)

(193)

Net income

7,690

7,690

Balance, June 30, 2024

160,786,740

$               161

$       934,194

$          (2,168)

$         15,389

$       947,576

Six Months Ended June 30, 2024

Common Stock

(IN THOUSANDS, EXCEPT SHARES)

Shares

Amount

Additional

paid-in

capital

Accumulated
other
comprehensive
loss

Retained
earnings

Total

stockholders’

equity

Balance, December 31, 2023

158,757,620

$               159

$       901,259

$             (916)

$            8,954

$       909,456

RSUs and MSUs vested

1,831,832

2

2

Option exercises

44,049

313

313

ESPP purchase

153,239

1,895

1,895

Stock-based compensation

30,727

30,727

Foreign currency translation adjustment

(1,252)

(1,252)

Net income

6,435

6,435

Balance, June 30, 2024

160,786,740

$               161

$       934,194

$          (2,168)

$         15,389

$       947,576

Three Months Ended June 30, 2023

Common Stock

(IN THOUSANDS, EXCEPT SHARES)

Shares

Amount

Additional

paid-in

capital

Accumulated
other
comprehensive
loss

Retained
earnings

Total

stockholders’

equity

Balance, March 31, 2023

154,811,980

$               154

$       824,498

$          (1,750)

$            4,862

$       827,764

RSUs and MSUs vested

1,218,542

2

2

Option exercises

248,553

2,878

2,878

Stock-based compensation

40,114

40,114

Foreign currency translation adjustment

(221)

(221)

Net income

7,677

7,677

Balance, June 30, 2023

156,279,075

$               156

$       867,490

$          (1,971)

$         12,539

$       878,214

Six Months Ended June 30, 2023

Common Stock

(IN THOUSANDS, EXCEPT SHARES)

Shares

Amount

Additional

paid-in

capital

Accumulated
other
comprehensive
loss

Retained
earnings

Total

stockholders’

equity

Balance, December 31, 2022

153,990,128

$               154

$       810,186

$          (2,899)

$               775

$       808,216

RSUs and MSUs vested

1,590,282

2

2

Option exercises

587,502

4,993

4,993

ESPP purchase

111,163

882

882

Stock-based compensation

51,429

51,429

Foreign currency translation adjustment

928

928

Adoption of ASC 326, net of tax

941

941

Net income

10,823

10,823

Balance, June 30, 2023

156,279,075

$               156

$       867,490

$          (1,971)

$         12,539

$       878,214

 

 

INTEGRAL AD SCIENCE HOLDING CORP.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(UNAUDITED)  

Six Months Ended June 30,

(IN THOUSANDS)

2024

2023

Cash flows from operating activities:

Net income

$              6,435

$            10,823

Adjustments to reconcile net income to net cash provided by operating activities:

Depreciation and amortization

30,789

26,346

Stock-based compensation

30,742

51,741

Foreign currency loss (gain), net

1,564

(1,239)

Deferred tax benefit

(3,456)

(37,535)

Amortization of debt issuance costs

232

232

Allowance for credit losses

745

1,254

Changes in operating assets and liabilities:

Increase in accounts receivable

(2,070)

(4,483)

Decrease in unbilled receivables

998

2,272

(Increase) decrease in prepaid expenses and other current assets

(19,548)

12,619

(Increase) decrease in operating leases, net

(618)

25

(Increase) decrease in other long-term assets

(557)

4

Decrease in accounts payable and accrued expenses and other long-term liabilities

(20,221)

(10,225)

(Decrease) increase in deferred revenue

(111)

350

Decrease in due to/from related party

(122)

(118)

Net cash provided by operating activities

24,802

52,066

Cash flows from investing activities:

Purchase of property and equipment

(1,323)

(1,810)

Development of internal use software and other

(18,836)

(14,928)

Net cash used in investing activities

(20,159)

(16,738)

Cash flows from financing activities:

Proceeds from the Revolver

75,000

Repayment of long-term debt

(60,000)

(105,000)

Proceeds from exercise of stock options

313

4,993

Cash received from Employee Stock Purchase Program

2,213

1,409

Net cash used in financing activities

(57,474)

(23,598)

Net (decrease) increase in cash, cash equivalents, and restricted cash

(52,831)

11,730

Effect of exchange rate changes on cash, cash equivalents and restricted cash

(1,084)

(142)

Cash, cash equivalents and restricted cash at beginning of period

127,290

89,671

Cash, cash equivalents, and restricted cash, at end of period

$            73,375

$          101,259

Supplemental Disclosures:

Net cash paid during the period for:

Interest

$              3,614

$              5,862

Taxes

$            19,925

$              5,609

Non-cash investing and financing activities:

Property and equipment acquired included in accounts payable

$                 108

$                 140

Internal use software acquired included in accounts payable

$                 661

$              1,159

Lease liabilities arising from right of use assets

$              5,278

$              3,902

 

Supplemental Disclosure Regarding Non-GAAP Financial Information

We use supplemental measures of our performance, which are derived from our consolidated financial information, but which are not presented in our consolidated financial statements prepared in accordance with GAAP. Adjusted EBITDA is the primary financial performance measure used by management to evaluate our business and monitor ongoing results of operations. Adjusted EBITDA is defined as income before depreciation and amortization, stock-based compensation, interest expense, income taxes, acquisition, restructuring and integration costs, foreign exchange gain, net, asset impairments, and other one-time, non-recurring costs. Adjusted EBITDA margin represents the adjusted EBITDA for the applicable period divided by the revenue for that period presented in accordance with GAAP.

We use non-GAAP financial measures to supplement financial information presented on a GAAP basis. We believe that excluding certain items from our GAAP results allows management to better understand our consolidated financial performance from period to period and better project our future consolidated financial performance as forecasts are developed at a level of detail different from that used to prepare GAAP-based financial measures. Moreover, we believe these non-GAAP financial measures provide our shareholders with useful information to help them evaluate our operating results by facilitating an enhanced understanding of our operating performance and enabling them to make more meaningful period-to-period comparisons. Although we believe these measures are useful to investors and analysts for the same reasons they are useful to management, as discussed below, these measures are not a substitute for, or superior to, U.S. GAAP financial measures or disclosures. Our non-GAAP financial measures may not be comparable to similarly titled measures of other companies. Other companies, including companies in our industry, may calculate non-GAAP financial measures differently than we do, limiting the usefulness of those measures for comparative purposes.

Reconciliations of historical adjusted EBITDA to its most directly comparable GAAP financial measure, net income/loss, are presented below. We encourage you to review the reconciliations in conjunction with the presentation of the non-GAAP financial measures for each of the periods presented. In future fiscal periods, we may exclude such items and may incur income and expenses similar to these excluded items.

Reconciliation of Adjusted EBITDA

Three Months Ended June 30,

Six Months Ended June 30,

(IN THOUSANDS, EXCEPT PERCENTAGES)

2024

2023

2024

2023

Net income

$         7,690

$         7,677

$         6,435

$      10,823

Depreciation and amortization

15,709

13,521

30,789

26,346

Stock-based compensation

15,004

40,435

30,742

51,741

Interest expense, net

1,536

3,221

3,462

6,638

Provision (benefit) for income taxes

4,923

(29,107)

4,789

(26,081)

Acquisition, restructuring and integration costs

1,048

809

1,174

1,621

Foreign exchange loss (gain), net

315

(631)

1,884

(1,147)

Asset impairments and other costs

1,469

1,506

Adjusted EBITDA

$       46,225

$       37,394

$       79,275

$      71,447

Revenue

$     129,005

$     113,651

$     243,535

$    219,743

Net income margin

6 %

7 %

3 %

5 %

Adjusted EBITDA margin

36 %

33 %

33 %

33 %

 

Conference Call and Webcast Information
IAS will host a conference call and live webcast to discuss its second quarter 2024 financial results today at 5:00 p.m. ET. To access the live webcast and conference call dial-in, please register under the “News & Events” section of IAS’s investor relations website. A replay will be available on IAS’s investor relations website following the live call: https://investors.integralads.com

About Integral Ad Science
Integral Ad Science (IAS) is a leading global media measurement and optimization platform that delivers the industry’s most actionable data to drive superior results for the world’s largest advertisers, publishers, and media platforms. IAS’s software provides comprehensive and enriched data that ensures ads are seen by real people in safe and suitable environments, while improving return on ad spend for advertisers and yield for publishers. Our mission is to be the global benchmark for trust and transparency in digital media quality. For more information, visit integralads.com.

Forward-Looking Statements
This earnings press release contains forward-looking statements that are subject to risks and uncertainties. All statements other than statements of historical fact included in this press release are forward-looking statements. Forward-looking statements give our current expectations and projections relating to our financial condition, results of operations, plans, objectives, future performance, including guidance, and business, including pipeline and industry trends. You can identify forward-looking statements by the fact that they do not relate strictly to historical or current facts. These statements may include words such as “anticipate,” “estimate,” “expect,” “project,” “plan,” “intend,” “believe,” “may,” “will,” “should,” “can have,” “likely,” and other words and terms of similar meaning in connection with any discussion of the timing or nature of future operating or financial performance or other events. For example, all statements we make relating to our estimated and projected costs, expenditures, cash flows, growth rates and financial results or our plans and objectives for future operations, growth initiatives or strategies, including pursuing business from Oracle or other competitors are forward-looking statements. All forward-looking statements are subject to risks and uncertainties that may cause actual results to differ materially from those that we expected, including: (i) the adverse effect on our business, operating results, financial condition, and prospects from various macroeconomic factors, including instability in geopolitical or market conditions; (ii) our failure to innovate or make the right investment decisions; (iii) our ability to provide digital or cross-platform analytics; (iv) our failure to maintain or achieve industry accreditation standards; (v) our dependence on integrations with advertising platforms, demand side providers (“DSPs”) and proprietary platforms that we do not control; (vi) our ability to compete successfully with our current or future competitors in an intensely competitive market, including with respect to the Oracle opportunity; (vii) our inability to use software licensed from third parties; (viii) our international expansion; (ix) our ability to expand into new channels; (x) our ability to sustain our profitability and revenue growth rate; (xi) risks that our customers do not pay or choose to dispute their invoices; (xii) risks of material changes to revenue share agreements with certain DSPs; (xiii) our dependence on the overall demand for advertising; (xiv) our ability to effectively manage our growth; (xv) the impact that any acquisitions we have completed in the past and may consummate in the future, strategic investments, or alliances may have on our business, financial condition, and results of operations; (xvi) our ability to successfully execute our international plans; (xvii) the risks associated with the seasonality of our market; (xviii) our ability to maintain high impression volumes; (xix) the difficulty in evaluating our future prospects given our short operating history; (xx) uncertainty in how the market for buying digital advertising verification solutions will evolve; (xxi) interruption by man-made problems such as terrorism, computer viruses, or social disruptions; (xxii) the risk of failures in the systems and infrastructure supporting our solutions and operations; (xxiii) our ability to avoid operational, technical, and performance issues with our platform; (xxiv) risks associated with any unauthorized access to user, customer, or inventory and third-party provider data; (xxv) our ability to provide the non-proprietary technology, software, products, and services that we use; (xxvi) the risk that we are sued by third parties for alleged infringement, misappropriation, or other violation of their proprietary rights; (xxvii) our ability to obtain, maintain, protect, or enforce intellectual property and proprietary rights that are important to our business; (xxviii) our involvement in lawsuits to protect or enforce our intellectual property; (xxix) risks that our employees, consultants, or advisors have wrongfully used or disclosed alleged trade secrets of their current or former employers; (xxx) risks that our trademarks and trade names are not adequately protected; (xxxi) the impact of unforeseen changes to privacy and data protection laws and regulation on digital advertising; (xxxii) our ability to maintain our corporate culture; (xxxiii) public health outbreaks, epidemics, pandemics, or other public health crises; (xxxiv) risks posed by earthquakes, fires, floods, and other natural catastrophic events; (xxxv) the risk that a perceived failure to comply with laws and industry self-regulation may damage our reputation; and (xxxvi) other factors disclosed in our filings with the SEC. Given these factors, as well as other variables that may affect our operating results, you should not rely on forward-looking statements, assume that past financial performance will be a reliable indicator of future performance, or use historical trends to anticipate results or trends in future periods.

We derive many of our forward-looking statements from our operating budgets and forecasts, which are based on many detailed assumptions. While we believe that our assumptions are reasonable, we caution that it is very difficult to predict the impact of known factors, and it is impossible for us to anticipate all factors that could affect our actual results. The forward-looking statements included in this press release are made only as of the date hereof. We undertake no obligation to update or revise any forward- looking statement as a result of new information, future events or otherwise, except as otherwise required by law.

Investor Contact:
Jonathan Schaffer
ir@integralads.com 

Media Contact:
press@integralads.com 

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/ias-reports-second-quarter-2024-financial-results-302212716.html

SOURCE Integral Ad Science, Inc.

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

Fitterfly Healthtech and Ascensia Diabetes Care Launch a 21-Day Diabetes Management Program on World Diabetes Day

Published

on

By

MUMBAI, India, Nov. 14, 2024 /PRNewswire/ — This World Diabetes Day, on 14th November, Fitterfly Healthtech and Ascensia Diabetes Care are joining hands to launch a complimentary 21-day Diabetes Management Program for Ascensia’s glucometer users. This initiative aims to make diabetes care simpler and more effective for people, offering them personalised support, expert guidance, and easy-to-use tools.

For many, managing diabetes can feel overwhelming. Even with the right tools, knowing where to start can be challenging and confusing. That’s why this 21-day program is designed to help users get started on a wellness journey and build lasting habits, as 21 days is the time it takes to set a habit. By simply scanning a QR code on the warranty page of Ascensia’s glucometer, users can join the Fitterfly program and access diet plans, a 24/7 AI wellness coach, group sessions with diabetes experts, glucose tracking and insights, food diary tracking, assessments, and more. With each step, this structured support brings confidence and clarity, helping users feel truly in control of their health.

Albertraj Balraj, Country Head and Director at Ascensia Diabetes Care India Pvt Ltd., commented, “Glucometers and Self-Monitoring Blood Glucose (SMBG) play an important role in effective blood sugar monitoring. Through this partnership, we aim to offer people a 360° solution by combining our world-class glucometer with Fitterfly’s advanced tools and expert support to make diabetes management truly simple for everyone. We want people to approach diabetes care with confidence and without fear.”

Dr Arbinder Singal, CEO & co-founder of Fitterfly Healthtech, added, “Lifestyle management remains the first line of therapy for type 2 diabetes. Our collaboration with Ascensia makes it easy for people to take control of their health and get started on a journey to lower their blood sugar sustainably. By linking their glucometer to our Fitterfly app, users can track their readings, gain insights, and learn to manage diabetes with ease.”

This partnership is a true example of two brands joining forces to reduce the diabetes burden in the country.

To know more about Fitterfly’s Diabetes Programs, visit Fitterfly.

About Fitterfly

Fitterfly is a leading Indian healthtech company specialising in digital therapeutic programs for managing diabetes, obesity, and heart disease. Co-founded in 2016 by Dr Arbinder Singal and Shailesh Gupta, the Mumbai-based company employs over 200 professionals, including doctors, nutritionists, fitness experts, and technologists. Fitterfly aims to improve metabolic health by focusing on conditions like prediabetes, diabetes, obesity, hypertension, and heart disease. Fitterfly has significantly contributed to health technology research, publishing over 80 papers and winning numerous awards, including the Economic Times Healthtech Startup of the Year 2022. Fitterfly has raised $16.6 million in funding, with its last round in June 2022 led by Amazon with support from Fireside Ventures, 9 Unicorns, and Venture Catalysts.

About Ascensia Diabetes Care

Ascensia Diabetes Care is a global company focused entirely on helping people with diabetes. Our mission is to empower those living with diabetes through innovative solutions that simplify and improve their lives. We are home to the world-renowned CONTOUR® portfolio of blood glucose monitoring systems and the exclusive global distribution partner for the Eversense® Continuous Glucose Monitoring Systems from Senseonics. Ascensia is a member of PHC Group and was established in 2016 through the acquisition of Bayer Diabetes Care by PHC Holdings Corporation. Ascensia products are sold in more than 100 countries. Ascensia has around 1,400 employees and operations in 29 countries. For further information, please visit the Ascensia Diabetes Care website at www.ascensia.com.

Photo: https://mma.prnewswire.com/media/2553921/Fitterfly_Ascensia_Launch.jpg

View original content to download multimedia:https://www.prnewswire.com/in/news-releases/fitterfly-healthtech-and-ascensia-diabetes-care-launch-a-21-day-diabetes-management-program-on-world-diabetes-day-302303822.html

Continue Reading

Technology

Eco-documentary A Chorus of Frogs officially launched

Published

on

By

NANJING, China, Nov. 14, 2024 /PRNewswire/ — Recently, the ecological documentary A Chorus of Frogs produced by Nanjing Newspaper Media Group was officially launched. The film told the story of Wang Ningjing, a post-95s Nanjing girl, who returned to the countryside to find the Chinese immaculate treefrog and shoot a documentary.

https://youtu.be/V8aI9PIFalA?si=Mcc6iP5FeAk3Y8OF

Wang Ningjing, the post-95s generation from Nanjing, is currently studying wildlife filmmaking in the UK. Professor Borzée Amaël from Nanjing Forestry University, who grew up in Madagascar, has been researching treefrogs over ten years.

Unlike most girls who like fairy tales, Wang has been passionate about creature and nature since childhood. Nanjing Hongshan Forest Zoo, not far from her home, was a place she often visited as a child.

“I see one. Is that it?……That one on the wheat. So beautiful!” The species’ breeding season is May and June. During this period, Professor Amaël conducted regular field surveys to locate populations of the treefrog, known for its unique calls that can be heard from a distance. The documentary began with Wang listening to the calls of the treefrog in the fields at night.

A Chorus of Frogs is positioned as an ecological and humanistic documentary. By following Wang Ningjing and Amer to explore the traces of the Chinese immaculate treefrog, it vividly tells the story of people and frogs.

Chinese path to modernization has the distinctive features of respecting nature, following its laws and protect it as well as promoting harmony between humans and nature. The harmonious coexistence between human and the environment is important not only to China but to the world as well.

Where does the Chinese immaculate treefrog go? I believe everyone will find their own answer after watching.

Nanjing Newspaper Media Group, a state-owned media group in Nanjing City, was established on December 17, 2002 with the approval from the National Press and Publication Administration. In recent years, the group has seized strategic opportunities for media convergence to develop a new type of mainstream media based on the Internet. Fully committed to mobile first, it has accelerated the establishment of all-media communication system. The group’s flagship brand, Zijinshan Video, focuses on short video creation, particularly the production of documentaries. It currently has more than 65 million followers across all platforms.

Video – https://www.youtube.com/watch?v=V8aI9PIFalA

View original content:https://www.prnewswire.co.uk/news-releases/eco-documentary-a-chorus-of-frogs-officially-launched-302305134.html

Continue Reading

Technology

Avathon Partners with CP PLUS, Largest CCTV Manufacturer in India, to Enhance Public Safety while Strengthening Community Bonds

Published

on

By

PLEASANTON, Calif., Nov. 13, 2024 /PRNewswire/ — Avathon, provider of the leading AI platform for industrial operations, has partnered with CP PLUS, one of the largest manufacturers of CCTV cameras, to create safer, more connected societies by bundling Avathon’s computer vision technology with each camera. The companies are bringing Avathon’s computer vision AI capabilities to small and medium-sized businesses (SMBs) across India, turning their cameras into intelligent assets that enable more secure workplaces, factories and facilities.           

In today’s fast-paced world, it’s hard to keep an eye on every single detail, every minute of the day. Computer vision AI technology gives users the freedom and control to go about their daily lives knowing they will receive proactive alerts identifying safety and security issues in real time.

“Increasing demand for advanced public safety tools, smart home devices and integrated AI-powered cameras is fueling massive industry growth,” said Aditya Khemka, Managing Director, CP PLUS, a subsidiary of Aditya Group. “Our partnership with Avathon will help us to better deliver state-of-the-art AI-powered solutions that feature advanced functions like real-time anomaly detection and intelligent monitoring.”

Avathon’s computer vision AI automatically detects and alerts unsafe conditions and incidents in real time, allowing users to proactively take the right actions. Avathon enables business owners using valuable resources to monitor CCTV camera feeds to get back to focusing on operations. The company partners with OEM camera manufacturers by providing AI technology that enables end customers to quickly and accurately address processes, behaviors, and conditions that cause unacceptable risk. Through its partnership with CP PLUS, Avathon has democratized this technology, giving access to large organizations and small businesses alike.

CP PLUS is India’s leading surveillance brand with the most extensive portfolio in the entire global industry. Representing a major share of the Indian CCTV market, CP PLUS offers a range of products and services to meet the varied needs of government, commercial, residential, and industrial customers and its products are successfully deployed in every nook and corner of India and many countries across verticals and industry.

“AI cameras are paving the path forward in India toward smart-city initiatives and enhanced public safety improvements. In this sometimes disconnected world, it’s comforting to rely on a technology that instantly alerts users to potential dangers and other anomalies,” said Pervinder Johar, CEO of Avathon. “We’re proud to partner with CP PLUS to provide the AI innovations needed to push India to the leading edge of technological advancement.”

About Avathon

Avathon, a leader in Industrial AI, extends the life of critical infrastructure while advancing the journey toward full autonomy. Avathon’s Industrial AI platform empowers commercial and government customers with scalable, secure, and value-driven solutions that enhance efficiency and resilience across heavy industry.

Media contact:

Jon Ross
Sr. PR & Communications Manager
Avathon
jross@avathon.com

View original content:https://www.prnewswire.com/news-releases/avathon-partners-with-cp-plus-largest-cctv-manufacturer-in-india-to-enhance-public-safety-while-strengthening-community-bonds-302304865.html

SOURCE Avathon

Continue Reading

Trending